Potential epidemiological and economical impact of two rotavirus vaccines in Colombia

Vaccine

Volumn 28, Issue 22, 2010, Pages 3856-3864

  De la Hoz, Fernando ^a   Alvis, Nelson ^b   Narváez, Javier ^a   Cediel, Natalia ^a,c   Gamboa, Oscar ^d   Velandia, Martha ^e  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^b UNIVERSIDAD DE CARTAGENA   (Colombia)

^c UNIVERSITY OF TURIN   (Italy)

^d Instituto Nacional de Cancerología   (Colombia)

^e Programa Ampliado de Inmunizaciones   (Colombia)

Author keywords

Colombia; Cost effectiveness; Rotavirus vaccine

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; BIRTH; COLOMBIA; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DECISION TREE; DIARRHEA; DRUG EFFICACY; DRUG STORAGE; GENOTYPE; HEALTH CARE COST; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROBABILITY; QUALITY OF LIFE; ROTAVIRUS INFECTION; TREATMENT DURATION; VACCINATION;

COLOMBIA; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DIARRHEA, INFANTILE; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION, SECONDARY; INFANT; MARKOV CHAINS; MODELS, ECONOMIC; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VACCINATION; VACCINES, ATTENUATED;

EID: 77952554582     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.03.004     Document Type: Article

References (49)

1. Kosek M., Bern C., and Guerrant R.L. The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000. Bull World Health Organ 81 3 (2003) 197-204
2. Parashar U.D., Hummelman E.G., Bresee J.S., Miller M.A., and Glass R.I. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 9 May (5) (2003) 565-572
3. Caceres D.C., Pelaez D., Sierra N., Estrada E., and Sanchez L. Burden of rotavirus-related disease among children under five, Colombia, 2004. Rev Panam Salud Publica 20 July (1) (2006) 9-21
4. De Vos B., Vesikari T., Linhares A.C., Salinas B., Perez-Schael I., Ruiz-Palacios G.M., et al. A rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritis. Pediatr Infect Dis J 23 October (10) Suppl. (2004) S179-S182
5. Perez-Schael I., Salinas B., Gonzalez R., Salas H., Ludert J.E., Escalona M., et al. Rotavirus mortality confirmed by etiologic identification in Venezuelan children with diarrhea. Pediatr Infect Dis J 26 May (5) (2007) 393-397
6. O'Ryan M., Pérez I., Mamani N., Peña A., Salinas B., González G., et al. Rotavirus-associated medical visits and hospitalizations in South America: a prospective study at three large sentinel hospitals. Pediatr Infect Dis J 20 (2001) 685-693
7. Walker D., Akramuzzaman S.M., and Lanata C.F. Future of research into rotavirus vaccine. Cost effectiveness of vaccine is being assessed. BMJ 322 January (7278) (2001) 106
8. Constenla D., O'Ryan M., Navarrete M.S., Antil L., and Rheingans R.D. Potential cost effectiveness of a rotavirus vaccine in Chile. Rev Med Chil 134 June (6) (2006) 679-688
9. Constenla D., Perez-Schael I., Rheingans R.D., Antil L., Salas H., and Yarzabal J.P. Evaluación del impacto económico de la vacuna antirrotavírica en Venezuela. Rev Panam Salud Publica 20 October (4) (2006) 213-222
10. Ruiz-Palacios G.M., Perez-Schael I., Velazquez F.R., Abate H., Breuer T., Clemens S.C., et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 354 January (1) (2006) 11-22
11. Manrique-Abril F.G., Tigne y Diane B., Bello S.E., and Ospina J.M. Diarrhoea-causing agents in children aged less than five in Tunja, Colombia. Rev Salud Publica (Bogota) 8 January-April (1) (2006) 88-97
12. Caceres D.C., Estrada E., DeAntonio R., and Pelaez D. Acute diarrheal disease: a public health challenge in Colombia. Rev Panam Salud Publica 17 January (1) (2005) 6-14
13. Urbina D., Rodriguez J.G., Arzuza O., Parra E., Young G., Castro R., et al. G and P genotypes of rotavirus circulating among children with diarrhea in the Colombian northern coast. Int Microbiol 7 June (2) (2004) 113-120
14. Urbina D., Arzuza O., Young G., Parra E., Castro R., and Puello M. Rotavirus type A and other enteric pathogens in stool samples from children with acute diarrhea on the Colombian northern coast. Int Microbiol 6 March (1) (2003) 27-32
15. Gutiérrez M., Urbina D., Matiz A., Puello M., Mercado M., Parra M., et al. Comportamiento de la diarrea causada por virus y bacterias en regiones cercanas a la zona ecuatorial. Colombia Médica 36 4 Suppl. 3 (2005) 6-14
16. Trujillo H., Robledo J., Mejía G., Tamayo M., Gomez C., and Mejía C. Etiología y clínica de la enfermedad diarreica aguda en 100 niños de un centro de salud de Medellin-Colombia. Revista Medicina UPB 10 2 (1991) 122-131
17. Mora J., Suescun J., Juliao O., and Guzman M. Estudio longitudinal sobre la etiología y epidemiología de la enfermedad diarreica aguda en los niños de una comunidad urbana pobre de Bogotá, Colombia. Escuela Colombiana de Medicina 1 (1988) 93-120
18. Bernal C., Zapata C., Durango H., and Alvarez C. Agentes etiológicos de diarrea en niños atendidos en la Unidad de Capacitación para el tratamiento de la Diarrea del Hospital Universitario San Vicente de Paúl de Medellín. Infectio 6 4 (2002) 204-211
19. Arango A., Aguirre C., Aristizabal L., and Hanssen H. Frecuencia de rotavirus en niños menores de cinco años con diarrea aguda. Primer informe. Estudio en un grupo de niños de la ciudad de Medellín (Colombia). Revista Salud Uninorte 2 3 (1985) 129-138
20. Remolina A., Rey F., García L., Arellana R., Llanos R., Clemow R., et al. Etiología de la enfermedad diarreica aguda (EDA) en Barranquilla, Colombia. Salud Uninorte 3 1 (1986) 15-23
21. Borrero M. Programa de control de enfermedades diarreicas en Cali, Colombia (1983), Organizacion Panamericana de la Salud, Washington, DC. http://hist.library.paho.org/Spanish/EPID/50919.pdf Available at: http://hist.library.paho.org/Spanish/EPID/50919.pdf
22. Martínez L., Matiz A., Trespalacios A., Ajami N., Mora C., Serrano P., et al. Etiología de la enfermedad diarreica aguda viral en niños menores de 5 años en la población de Quibdó Pediatría 40 1 (2005) 23-32
23. Bermeo L., Mogollón D., Ariza F., Barrera J., Jerabek L., and Gutierrez M. Molecular characterization of rotavirus strains obtained from human diarrheic samples and their epidemiological implications. Revista de la Facultad de Ciencias, Pontificia Universidad Javeriana 4 1 (1997) 71-81
24. Urbina D., and Cortez A. Determinación de rotavirus en niños con enfermedad diarreica aguda (EDA). Ciencia, tecnología y educación 6 (1984) 27-38
25. Trujillo H., Jaramillo C., Restrepo M., Mejía G., Zapata T., Ramírez R., et al. Rotavirus y otros enteropatógenos en la etiología de la diarrea aguda en Medellín, Colombia, 1982. Bol of Sanita Panam 98 (1985) 251-259
26. Máttar S., Pulido N., Mulett R., Londoño D., Medina G., and Martinez M. Aetiology of acute infectious diarrhoea in a private hospital in Colombia. Med Sci Res 27 (1999) 29-32
27. Leal F., Franco G., Sandoval C., Gómez E., Buitrago B., and Rodríguez G. Agentes etiológicos de la diarrea aguda en Bogotá. Labimed (1993 Junio-Julio) 5-21
28. Bertranou F.M. Are market-oriented health insurance reforms possible in Latin America?: the cases of Argentina, Chile and Colombia. Health Policy 47 1 (1999) 19-36
29. Prieto F., and De la Hoz F. Evaluación de la jornada nacional de vacunación en Bogotá D.C. Rev Salud Pública 5 2 (2003) 144-157
30. Linhares A.C., and Bresee J.S. Rotavirus vaccines and vaccination in Latin America. Rev Panam Salud Publica 8 November (5) (2000) 305-331
31. PROFAMILIA. Encuesta Nacional de Demografia y Salud Bogota, DC; 2005.
32. Velázquez F.R., Calva J.J., Glass M.L.G., Pickering R., and Ruiz-Palacios G L. Cohort study of rotavirus serotype patterns in symptomatic and asymptomatic infection in Mexican children. Pediatr Infect Dis J 12 (1993) 54-61
33. Salinas B., Perez Schael I., Linhares A.C., Ruiz Palacios G.M., Guerrero M.L., Yarzabal J.P., et al. Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: a randomized, placebo-controlled trial in Latin American infants. Pediatr Infect Dis J 24 September (9) (2005) 807-816
34. Kane E.M., Turcios R.M., Arvay M.L., Garcia S., Bresee J.S., and Glass R.I. The epidemiology of rotavirus diarrhea in Latin America. Anticipating rotavirus vaccines. Rev Panam Salud Publica 16 December (6) (2004) 371-377
35. Concha Eastman A., Melo M., Korgi M., De Borrero M., and Delgado F. Vigilancia epidemiologica de la mortalidad por enfermedad diarreica en niños menores de cinco años en Cali, Colombia. Colombia Medica 26 4 (1995) 125-131
36. Vesikari T., Matson D., Dennehy P., Van Damme P., Santosham M., Rodriguez Z., et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 354 (2006) 23-33
37. Newall A.T., Beutels P., Macartney K., Wood J., and MacIntyre C.R. The cost-effectiveness of rotavirus vaccination in Australia. Vaccine 25 December (52) (2007) 8851-8860
38. WHO. Report of the commission on the macroeconomics and health: investing in health for economic developments (2001), World Health Organization, Geneva
39. Rheingans R.D., Constenla D., Antil L., Innis B.L., and Breuer T. Potential cost-effectiveness of vaccination for rotavirus gastroenteritis in eight Latin American and Caribbean countries. Rev Panam Salud Publica 21 April (4) (2007) 205-216
40. Constenla D., Ortega-Barria E., Rheingans R.D., Antil L., and Saez-Llorens X. Economic impact of rotavirus vaccination in Panama. An Pediatr (Barc) 68 February (2) (2008) 128-135
41. Constenla D.O., Linhares A.C., Rheingans R.D., Antil L.R., Waldman E.A., and da Silva L.J. Economic impact of a rotavirus vaccine in Brazil. J Health Popul Nutr 26 December (4) (2008) 388-396
42. De Soarez P., Valentim J., Sartori A., and Novaez H.M.D. Cost effectiveness analysis of rotavirus vaccination in Brazil. Rev Panam Salud Publica 23 4 (2008) 221-230
43. Valencia-Mendoza A., Bertozzi S., Gutierrez J., and Itzler R. Cost-effectiveness of introducing a rotavirus vaccine in developing countries: the case of Mexico. BMC Infect Dis 8 (2008) 103
44. Urbina D., Young G., and Arzuza O. Viral gastroenteritis and diversity of rotavirus strains in Colombian children: a systematic review. J Infect Dev Countries 2 2 (2008) 99-105
45. Castello A., Arvay M., Glass R., and Gentsch J. Rotavirus strain surveillance in Latin America. A review of the last nine years. Pediatr Infect Dis J 23 (2004) S168-S172
46. Melliez H., Levybruhl D., Boelle P.Y., Dervaux B., Baron S., and Yazdanpanah Y. Cost and cost-effectiveness of childhood vaccination against rotavirus in France. Vaccine 26 January (5) (2008) 706-715
47. Melliez H., Boelle P.Y., Baron S., Mouton Y., and Yazdanpanah Y. Effectiveness of childhood vaccination against rotavirus in sub-Saharan Africa: the case of Nigeria. Vaccine 25 January (2) (2007) 298-305
48. Jit M., and Edmunds W.J. Evaluating rotavirus vaccination in England and Wales. Part II. The potential cost-effectiveness of vaccination. Vaccine 25 May (20) (2007) 3971-3979
49. De la Hoz F., Pérez L., De Neira M., Wheeler J., and Hall A. Vaccination coverage with hepatitis B and other vaccines in children from the Colombian Amazon. Do health workers knowledge influence coverage?. Trop Med Int Health 10 4 (2005) 322-329